Lanlan Yu

4.9k total citations · 2 hit papers
20 papers, 3.3k citations indexed

About

Lanlan Yu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Lanlan Yu has authored 20 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Lanlan Yu's work include Angiogenesis and VEGF in Cancer (8 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Retinal Diseases and Treatments (3 papers). Lanlan Yu is often cited by papers focused on Angiogenesis and VEGF in Cancer (8 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Retinal Diseases and Treatments (3 papers). Lanlan Yu collaborates with scholars based in United States, China and Singapore. Lanlan Yu's co-authors include Napoleone Ferrara, Martin A. Gorovsky, Xiumin Wu, Cuiling Zhong, C. David Allis, Josephine Bowen, Wei Yi, Farbod Shojaei, Y. Gloria Meng and Xueping Qu and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Lanlan Yu

20 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phosphorylation of Histone H3 Is Required for Proper Chromosome Condensation and Segregation

1999 587 citations Wei Yi, Lanlan Yu et al. Cell profile →
Bv8 regulates myeloid-cell-dependent tumour angiogenesis

2007 522 citations Farbod Shojaei, Xiumin Wu et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lanlan Yu United States	16	2.1k	1.1k	807	690	330	20	3.3k
Matthew L. Fero United States	22	2.6k 1.2×	1.9k 1.7×	477 0.6×	517 0.7×	507 1.5×	32	4.4k
Arito Yamane Japan	22	3.4k 1.6×	817 0.7×	1.2k 1.5×	648 0.9×	207 0.6×	50	4.5k
Bernd Hinzmann Germany	24	1.7k 0.8×	808 0.7×	361 0.4×	958 1.4×	331 1.0×	47	3.0k
Ellen van Drunen Netherlands	27	2.5k 1.2×	960 0.9×	243 0.3×	541 0.8×	232 0.7×	42	3.7k
Sharon Brookes United Kingdom	29	2.4k 1.1×	1.4k 1.2×	457 0.6×	513 0.7×	333 1.0×	44	3.4k
Mathias François Australia	37	1.7k 0.8×	1.3k 1.1×	274 0.3×	332 0.5×	506 1.5×	73	3.1k
H Matsushime United States	16	3.4k 1.6×	2.7k 2.4×	556 0.7×	653 0.9×	844 2.6×	21	5.0k
Christine Campbell United States	28	1.9k 0.9×	798 0.7×	374 0.5×	432 0.6×	105 0.3×	55	3.0k
Dalia Resnitzky Israel	18	2.7k 1.3×	2.3k 2.0×	604 0.7×	410 0.6×	753 2.3×	21	3.8k
Mario Tosi France	38	2.1k 1.0×	497 0.4×	703 0.9×	352 0.5×	199 0.6×	87	4.3k

Countries citing papers authored by Lanlan Yu

Since Specialization

Citations

This map shows the geographic impact of Lanlan Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lanlan Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lanlan Yu more than expected).

Fields of papers citing papers by Lanlan Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lanlan Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lanlan Yu. The network helps show where Lanlan Yu may publish in the future.

Co-authorship network of co-authors of Lanlan Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Lanlan Yu. A scholar is included among the top collaborators of Lanlan Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lanlan Yu. Lanlan Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tseng, Min, et al.. (2023). Zoledronic acid and ibandronate-induced nephrotoxicity in 2D and 3D proximal tubule cells derived from human and rat. Toxicological Sciences. 198(1). 86–100. 5 indexed citations

Wang, Han, et al.. (2023). The roles of lncRNAs in Th17-associated diseases, with special focus on JAK/STAT signaling pathway. Clinical and Experimental Medicine. 23(7). 3349–3359. 1 indexed citations

Zhang, Ming‐Zhi, Haojie Sun, Ming Su, et al.. (2018). COPI-Mediated Nuclear Translocation of EGFRvIII Promotes STAT3 Phosphorylation and PKM2 Nuclear Localization. International Journal of Biological Sciences. 15(1). 114–126. 10 indexed citations

Yang, Jihong, Xiangdan Wang, Germaine Fuh, et al.. (2014). Comparison of Binding Characteristics and In Vitro Activities of Three Inhibitors of Vascular Endothelial Growth Factor A. Molecular Pharmaceutics. 11(10). 3421–3430. 71 indexed citations

Qu, Xueping, Guanglei Zhuang, Lanlan Yu, Gloria Meng, & Napoleone Ferrara. (2012). Induction of Bv8 Expression by Granulocyte Colony-stimulating Factor in CD11b+Gr1+ Cells. Journal of Biological Chemistry. 287(23). 19574–19584. 78 indexed citations

Yu, Lanlan, Xiao Liang, & Napoleone Ferrara. (2011). Comparing protein VEGF inhibitors: In vitro biological studies. Biochemical and Biophysical Research Communications. 408(2). 276–281. 72 indexed citations

Crawford, Yongping, Ian Kasman, Lanlan Yu, et al.. (2009). PDGF-C Mediates the Angiogenic and Tumorigenic Properties of Fibroblasts Associated with Tumors Refractory to Anti-VEGF Treatment. Cancer Cell. 15(1). 21–34. 481 indexed citations

Shojaei, Farbod, Xiumin Wu, Xueping Qu, et al.. (2009). G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models. Proceedings of the National Academy of Sciences. 106(16). 6742–6747. 392 indexed citations

Shojaei, Farbod, Cuiling Zhong, Xiumin Wu, Lanlan Yu, & Napoleone Ferrara. (2008). Role of myeloid cells in tumor angiogenesis and growth. Trends in Cell Biology. 18(8). 372–378. 127 indexed citations

10.

Yu, Lanlan, Xiumin Wu, Zhiyong Cheng, et al.. (2008). Interaction between Bevacizumab and Murine VEGF-A: A Reassessment. Investigative Ophthalmology & Visual Science. 49(2). 522–522. 138 indexed citations

11.

Shojaei, Farbod, Xiumin Wu, Cuiling Zhong, et al.. (2007). Bv8 regulates myeloid-cell-dependent tumour angiogenesis. Nature. 450(7171). 825–831. 522 indexed citations breakdown →

12.

Gerber, Hans‐Peter, Xiumin Wu, Lanlan Yu, et al.. (2007). Mice expressing a humanized form of VEGF-A may provide insights into the safety and efficacy of anti-VEGF antibodies. Proceedings of the National Academy of Sciences. 104(9). 3478–3483. 77 indexed citations

13.

Tejada, Max L., Lanlan Yu, Jianying Dong, et al.. (2006). Tumor-Driven Paracrine Platelet-Derived Growth Factor Receptor α Signaling Is a Key Determinant of Stromal Cell Recruitment in a Model of Human Lung Carcinoma. Clinical Cancer Research. 12(9). 2676–2688. 94 indexed citations

14.

Dong, Jianying, Max L. Tejada, Frank Peale, et al.. (2004). VEGF‐null cells require PDGFR α signaling‐mediated stromal fibroblast recruitment for tumorigenesis. The EMBO Journal. 23(14). 2800–2810. 228 indexed citations

15.

Gille, Hendrik, Joe Kowalski, Lanlan Yu, et al.. (2000). A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth factor-dependent phosphatidylinositol 3′-kinase activation and endothelial cell migration. The EMBO Journal. 19(15). 4064–4073. 142 indexed citations

16.

Yu, Lanlan & Martin A. Gorovsky. (1999). Chapter 30 Protein Tagging in Tetrahymena. Methods in cell biology. 62. 549–559. 4 indexed citations

17.

Yi, Wei, Lanlan Yu, Josephine Bowen, Martin A. Gorovsky, & C. David Allis. (1999). Phosphorylation of Histone H3 Is Required for Proper Chromosome Condensation and Segregation. Cell. 97(1). 99–109. 587 indexed citations breakdown →

18.

Yu, Lanlan & Martin A. Gorovsky. (1997). Constitutive Expression, Not a Particular Primary Sequence, Is the Important Feature of the H3 Replacement Variant hv2 in Tetrahymena thermophila. Molecular and Cellular Biology. 17(11). 6303–6310. 40 indexed citations

19.

Yu, Lanlan, et al.. (1995). Linker histories are not essential and affect chromatin condensation in vivo. Cell. 82(1). 47–56. 249 indexed citations

20.

Yu, Lanlan, Piroska E. Szabó, Thaddeus W. Borun, & Wolf Prensky. (1978). The Localization of the Genes Coding for Histone H4 in Human Chromosomes. Cold Spring Harbor Symposia on Quantitative Biology. 42(0). 1101–1105. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact